China's Medtech Merger Wave: Zylox-Tonbridge Puts $189M on LifeTech Scientific to Build a Cardiovascular Device Platform
· techtimes.com · popularity 19/100 · 0 similar stories today
Read the original at techtimes.com →
Summary
Zylox-Tonbridge and GL Capital have conditionally agreed to subscribe for 16.7% of LifeTech Scientific for $189M, with explicit plans to pursue a full merger of China's top cardiovascular device makers.
Found in: Tech Times. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 9.